Associated Banc-Corp’s Inovio Pharmaceuticals INO Stock Holding History

Associated Banc-Corp’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8	Closed	-$1K	–	577
2020 Q4	$1K	Buy	+8	New	+$1.06K	﹤0.01%	922

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Associated Banc-Corp's INO Position: Q1 2021 in Review

Associated Banc-Corp sold out of Inovio Pharmaceuticals (INO) in Q1 2021, closing a stake of 8 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in INO in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 218 funds tracked by Wall St. Rank hold INO as of Q1 2021.

Associated Banc-Corp reported no remaining Inovio Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Associated Banc-Corp sold 8 Inovio Pharmaceuticals shares in Q1 2021, an estimated $1K.
Associated Banc-Corp first reported a position in Inovio Pharmaceuticals in Q4 2020 and held it in 1 quarter.
Associated Banc-Corp's Inovio Pharmaceuticals position peaked at $1K in Q4 2020.
218 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.